Isaac Francis

Solana remains in a cautious consolidation phase as traders wait for a clearer signal on the token’s next major direction.

Ethereum remains under market pressure in 2026, but analysts say its long-term investment case continues to draw support from onchain data.

Assembly Biosciences (NASDAQ:ASMB) announced plans to expand the clinical development framework for its experimental compound ABI-6250, pushing the asset beyond its initial virology target into chronic cholestatic liver conditions.

AC Immune (NASDAQ:ACIU) announced positive preliminary Phase 1 clinical data for its experimental brain imaging agent, ACI-19626, expanding its diagnostic reach into amyotrophic lateral sclerosis (ALS).

Ascentage Pharma (NASDAQ:AAPG) announced that abstracts for six of its clinical studies have been published ahead of the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, outlining early-phase therapeutic activity across its core pipeline of targeted oncology candidates.

Bitcoin is showing signs of a developing liquidity-driven rally toward $80,000 as more than $4 billion in leveraged short positions remain vulnerable to liquidation above that level.

The Coinbase premium dropped to its lowest level this month on May 21, highlighting intensifying institutional selling pressure across the crypto market.

A newly unsealed court filing in the Terraform Labs bankruptcy case alleged Jane Street used a private Telegram channel to obtain nonpublic information before the collapse of TerraUSD in 2022.

Tuas (ASX:TUA) has terminated its high-profile sale and purchase agreement to acquire shares in M1.

The United States Department of the Treasury intensified its crackdown on Iran-linked cryptocurrency activity after freezing nearly $500 million in digital assets under Operation Economic Fury.